UFP Technologies reported a net income of $4.2 million, or $0.55 per diluted share, for Q1 2021, compared to $3.9 million, or $0.52 per diluted share, for the same quarter in 2020. Sales for the quarter were $48.6 million, slightly exceeding the $48.3 million reported in Q1 2020. The company saw strong growth in Aerospace & Defense and Consumer markets, with medical sales showing progress compared to the last two quarters of 2020.
Net income increased to $4.2 million, or $0.55 per diluted share, compared to $3.9 million, or $0.52 per diluted share, in Q1 2020.
Sales for the first quarter were $48.6 million, slightly above the $48.3 million reported in Q1 2020.
Medical market showed progress with a smaller decrease compared to Q4 2020, as elective procedures began to resume.
Aerospace & Defense and Consumer markets experienced strong growth, increasing by 68% and 62%, respectively.
Analyze how earnings announcements historically affect stock price performance